Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 11, 2021
Date Accepted: Nov 30, 2021

The final, peer-reviewed published version of this preprint can be found here:

Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings

Voillot P, Riche B, Portafax M, Foulquié P, Gedik A, Barbarot S, Misery L, Heas S, Mebarki A, Texier N, Schück S

Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings

J Med Internet Res 2022;24(1):e31140

DOI: 10.2196/31140

PMID: 35089160

PMCID: 8838596

Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings.

  • Paméla Voillot; 
  • Brigitte Riche; 
  • Michel Portafax; 
  • Pierre Foulquié; 
  • Anaïs Gedik; 
  • Sébastien Barbarot; 
  • Laurent Misery; 
  • Stéphane Heas; 
  • Adel Mebarki; 
  • Nathalie Texier; 
  • Stéphane Schück

ABSTRACT

Background:

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory disease that occurs most frequently in children but also affects many adults. Social media have become key tools for finding and disseminating medical information.

Objective:

To identify the main themes of discussion, the difficulties encountered by patients with respect to atopic dermatitis and the impact of the pathology on quality of life (physical, psychological, social, or financial), but also to study the perception of patients regarding their treatment.

Methods:

A retrospective study was carried out by collecting social media posts in French language written by internet users mentioning their experience with atopic dermatitis, their quality of life and their treatments. Messages related to AD discomfort posted between July 1, 2010 and October 23, 2020 were extracted from French-speaking publicly available online forums. Automatic and manual extractions were implemented to create a general corpus and two sub-corpuses depending on the control of the disease.

Results:

A total of 33 115 messages associated with AD were included in the analysis corpus after extraction and cleaning. These messages were posted by 15 857 separate web users, most of them being women younger than 40 years. Tips to manage eczema and everyday hygiene/treatments were among the most discussed topics for Controlled AD sub-corpus, while baby-related topics and therapeutic failure were among the most discussed topics for Insufficiently Controlled AD sub-corpus. Quality of life was discussed in both sub-corpuses with a higher proportion in the Controlled AD sub-corpus. Treatments and their perception were also discussed by web users.

Conclusions:

More than just emotional or peer support, AD patients turn to online forums to discuss their health. Our findings show the need for an intersection between social media and health care and the importance of developing new approaches such as Atopic Dermatitis Control Tool (ADCT) focused on patients with AD. Clinical Trial: Not applicable (not a trial)


 Citation

Please cite as:

Voillot P, Riche B, Portafax M, Foulquié P, Gedik A, Barbarot S, Misery L, Heas S, Mebarki A, Texier N, Schück S

Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings

J Med Internet Res 2022;24(1):e31140

DOI: 10.2196/31140

PMID: 35089160

PMCID: 8838596

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.